Anand Divakaran

8PUBLICATIONS
14CO-AUTHORS
Epigenetics (incl. genome methylation and epigenomics)Industrial molecular engineering of nucleic acids and proteinsBiologically active moleculesCharacterisation of biological macromoleculesCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Mar 27, 2023
Recent progress and structural analyses of domain-selective BET inhibitors.

Anand Divakaran, Daniel A Harki, William C K Pomerantz

|Oct 20, 2022
Development of an N-Terminal BRD4 Bromodomain-Targeted Degrader.

Anand Divakaran, Cole R Scholtz, Huda Zahid

|Jan 10, 2022
A Structure-based Design Approach for Generating High Affinity BRD4 D1-Selective Chemical Probes.

Huarui Cui, Anand Divakaran, Zachariah J Hoell

|Jul 08, 2021
4-Methyl-1,2,3-Triazoles as N-Acetyl-Lysine Mimics Afford Potent BET Bromodomain Inhibitors with Improved Selectivity.

Huarui Cui, Angela S Carlson, Mary A Schleiff

|Sep 25, 2020
Selective N-Terminal BET Bromodomain Inhibitors by Targeting Non-Conserved Residues and Structured Water Displacement*.

Huarui Cui, Anand Divakaran, Anil K Pandey

Pageof 2